Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Third Harmonic Bio Inc.

THRD
Current price
13.57 USD +0.32 USD (+2.42%)
Last closed 13.25 USD
ISIN US88427A1079
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 493 169 984 USD
Yield for 12 month +130.00 %
1Y
3Y
5Y
10Y
15Y
THRD
21.11.2021 - 28.11.2021

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is also developing THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated skin, respiratory, and gastrointestinal conditions. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California. Address: 1700 Montgomery Street, San Francisco, CA, United States, 94111

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

19 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-35 000 USD

Last Year

-38 000 USD

Current Quarter

-12 000 USD

Last Quarter

-12 000 USD

Key Figures THRD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -46 563 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -10.56 %
PEG Ratio
Return On Equity TTM -12.25 %
Wall Street Target Price 19 USD
Revenue TTM
Book Value 6.31 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.82 USD
Diluted Eps TTM -0.82 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics THRD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History THRD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation THRD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.0936
Price Book MRQ 1.9179

Financials THRD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators THRD

For 52 weeks

5.73 USD 16.94 USD
50 Day MA 12.06 USD
Shares Short Prior Month 1 712 712
200 Day MA 11.09 USD
Short Ratio 24.24
Shares Short 1 783 249
Short Percent 9.6 %